Posts for Ticker ‘COHR’

Earnings Confessions Starting (AFFX, BEAV, COHR, CONN, NTY, ORBK)

BurningmoneyAs we are entering earnings season, we are also starting to get "confession season" where companies begin issuing updates ahead of their formal earnings.  Some of these will make some obvious sense, and others are almost counter-intuitive. Here is a look at some recent annooucements.

Read More »

The 52-Week Low Club (MSO)(TUES)

First Marblehead (FMD) Provides products for private education lending markets. Problems at SLM are not helping. Down to $11.69 from 52-week high of $57.56.

Martha Stewart Living  (MSO) A lot of bad news in print advertising today. Shares move down to $9.38 from 52-week high of $23.21.

Tuesday Morning (TUES) Retailer warns on profits. Falls to $4.41 from 5-week high of $18.50.

Coherent  (COHR) Company taken out of the S&P SmallCap 600. Drops to $24.85 from 52-week high of $33.38.

Douglas A. McIntyre

Pre-Market Stock News (December 18, 2007)

Below is the top news that 247WallSt.com is focusing on that is impacting stocks in pre-market trading activity:

  • Adobe Systems (ADBE) traded down 2% after beating earnings and slightly raised guidance.
  • ATS Medical (ATSI) received FDA approval for AP360 mechanical heart valve.
  • Best Buy (BBY) $0.53 EPS vs $0.41 est. and $9.92 Billion revenues vs. $9.45 Billion est.; shares traded up 4%.
  • Borg Warner (BWA) trades ex-split to reflect a 2 for 1 stock split today.
  • Cherokee (CHKE) retained Goldman, Sachs & Co. to explore strategic alternatives including possible sale of the company.
  • Dollar Financial (DLLR) raised fiscal 2008 guidance after formally closing its previously announced acquisition of 82 Florida financial-services stores.
  • Eli Lilly (LLY) announced that CEO Sidney Taurel will retire in March 2008.
  • First Solar (FSLR) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.
  • Forest Labs (FRX) won FDA approval for its new high blood pressure beta blocker along with Maylan Labs.
  • Goldman Sachs (GS) set to report earnings with $6.61 EPS estimate (whisper of $7.00 and higher).
  • Natus Medical (BABY) put Q1 guidance $0.09-0.10 vs $0.12 estimate; sees 2008 EPS $0.68 to $0.70 vs. $0.63 estimate.
  • MedcoHealth Solutions (MHS) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.
  • Mylan Labs (MYL) won FDA approval for its new high blood pressure beta blocker along with Forest Labs.
  • Range Resources (RRC) to replace Tribune in S&P 500 Index on Thursday after close.
  • Salix Pharmaceuticals (SLXP) will replace Coherent Inc. (COHR) in the S&P SmallCap 600 after the close TODAY.
  • Synovus (SNV) lowered its guidance.
  • Thornburg (TMO) reinstated dividend with $0.25 payment, says mortgage uncertainties continue.
  • Transocean (RIG) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.

Jon C. Ogg
December 18, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.